batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ESMO 2023 preview – conjugates, bispecifics and more 4 September 2023 ESMO 2023 preview – a few small molecules 4 September 2023 ESMO 2023 preview – going beyond PD-1 4 September 2023 Roche could take another targeted treatment into adjuvant lung cancer 1 September 2023 DualityBio and BioNTech take on Enhertu in HER2 low 31 August 2023 Green light for Seagen's pivotal integrin beta-6 trial 29 August 2023 Moderna gets into Claudin18.2 21 August 2023 Merck hints at progress beyond Welireg’s approved niche 18 August 2023 Load More